Home > News > Cancer study gets tiny
October 30th, 2007
Cancer study gets tiny
Abstract:
Joe DeSimone, who has a joint professorship at UNC-CH and N.C. State University, said he hopes his technology to deliver drugs to specific cells will begin clinical trials in about 14 months.
UNC-CH materials science professor Otto Zhou, whose work involves carbon nanotubes, thinks that a company he co-founded will produce new imaging devices for humans in less than two years. He says it has the potential to replace conventional X-rays.
The products of Zhou, DeSimone and other scientists are closer to market in part because of an alliance begun three years ago by the National Cancer Institute. Looking for a way to capitalize on nanotechnology's potential in cancer research, the institute brought together university scientists and private companies from across the country.
Source:
newsobserver.com
Related News Press |
Nanomedicine
Diamond glitter: A play of colors with artificial DNA crystals May 17th, 2024
Advances in priming B cell immunity against HIV pave the way to future HIV vaccines, shows quartet of new studies May 17th, 2024
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Gene therapy relieves back pain, repairs damaged disc in mice: Study suggests nanocarriers loaded with DNA could replace opioids May 17th, 2024
Oscillating paramagnetic Meissner effect and Berezinskii-Kosterlitz-Thouless transition in cuprate superconductor May 17th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||